Multi-component pharmaceutical dosage form
View Patent ↗A multi-component pharmaceutical dosage form comprising a plurality of drug substance—containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form by a weld between parts of the assembled dosage form.
1. A multi-component dosage form comprising:
a plurality of sub-units disposed in end-to-end relationship, each of the plurality of sub-units selected from a group comprising (i) capsule compartment sub-units respectively comprising at least one cavity formed therein and being configured to release a drug-substance contained within the at least one cavity into a gastro-intestinal environment and (ii) solid sub-units comprising a matrix of a polymer;
a first joint formed between a first sub-unit of the plurality of sub-units and a second sub-unit of the plurality of sub-units, the first joint comprising a plug formed as a unitary part of the first sub-unit and a socket formed as a unitary part of the second sub-unit; and
a second joint formed between the first sub-unit and a third sub-unit of the plurality of sub-units, the second joint comprising a socket formed as a unitary part of the first sub-unit and a plug formed as a unitary part of the third sub-unit;
wherein at least one of the first joint and the second joint between respective sub-units is formed such that a relative axial position between respective sub-units is solely delimited by engaging outer wall axial end parts of the respective sub-units;
wherein the first sub-unit is a capsule compartment sub-unit comprising a first cavity including an open end and a closed end and the third sub-unit is a capsule compartment sub-unit comprising a second cavity including an open end and a closed end; and
wherein the open end of the first cavity of the first sub-unit is disposed adjacent the open end of the second cavity of the third sub-unit and the first and second cavities form a combined cavity configured to contain a drug-substance therein.
2. The multi-component dosage form according to claim 1 , wherein the plug formed as a unitary part of the first sub-unit is disposed adjacent a first axial end of the first sub-unit and the first sub-unit further includes a socket formed as a unitary part of the first-sub-unit disposed adjacent a second axial end of the first sub-unit.
3. The multi-component dosage form according to claim 1 , wherein the second sub-unit is a solid sub-unit comprising a matrix of a polymer.
4. The multi-component dosage form according to claim 1 , further including a third joint formed between the second sub-unit and a fourth sub-unit of the plurality of sub-units, the third joint comprising a socket formed as a unitary part of the fourth sub-unit and a plug formed as a unitary part of the second sub-unit.
5. The multi-component dosage form according to claim 4 , wherein the fourth sub-unit is a capsule compartment sub-unit comprising at least one cavity formed therein and containing a first drug-substance.
6. The multi-component dosage form according to claim 5 , wherein the first sub-unit contains a second drug-substance.
7. The multi-component dosage form according to claim 6 , wherein the first drug-substance differs in composition and/or release characteristics from the second drug-substance.
8. The multi-component dosage form according to claim 4 , wherein the second and fourth sub-units are capsule compartment sub-units respectively comprising at least one cavity formed therein and containing a drug-substance.
9. The multi-component dosage form according to claim 4 , wherein the second sub-unit is a solid sub-unit comprising a matrix of a polymer and the fourth sub-unit is a capsule compartment sub-unit comprising at least one cavity formed therein and containing a drug-substance.
10. The multi-component dosage form according to claim 4 , wherein the fourth sub-unit is a solid sub-unit comprising a matrix of a polymer.
11. The multi-component dosage form according to claim 10 , wherein the second sub-unit is a capsule compartment sub-unit comprising a cavity formed therein and containing a drug-substance.
12. The multi-component dosage form according to claim 3 , wherein the second sub-unit comprises a through-hole formed therein extending from a first axial end of the second sub-unit to a second axial end of the second sub-unit.
13. A multi-component dosage form comprising:
a plurality of sub-units disposed in end-to-end relationship, each of the plurality of sub-units selected from a group comprising (i) capsule compartment sub-units respectively comprising at least one cavity formed therein and being configured to release a drug-substance contained within the at least one cavity into a gastro-intestinal environment and (ii) solid sub-units comprising a matrix of a polymer;
a first joint formed between a first sub-unit of the plurality of sub-units and a second sub-unit of the plurality of sub-units, the first joint comprising a plug formed as a unitary part of the first sub-unit and a socket formed as a unitary part of the second sub-unit; and
a second joint formed between the first sub-unit and a third sub-unit of the plurality of sub-units, the second joint comprising a socket formed as a unitary part of the first sub-unit and a plug formed as a unitary part of the third sub-unit;
wherein the plug formed as a unitary part of the first sub-unit is disposed adjacent a first axial end of the first sub-unit and the socket formed as a unitary part of the first sub-unit is disposed adjacent a second axial end of the first sub-unit;
wherein the first sub-unit is a capsule compartment sub-unit comprising a first cavity including an open end and a closed end and the third sub-unit is a capsule compartment sub-unit comprising a second cavity including an open end and a closed end; and
wherein the open end of the first cavity of the first sub-unit is disposed adjacent the open end of the second cavity of the third sub-unit and the first and second cavities form a combined cavity configured to contain a drug-substance therein.
14. The multi-component dosage form according to claim 13 , wherein at least one of the first joint and the second joint between respective sub-units is formed such that a relative axial position between respective sub-units is solely delimited by engaging outer wall axial end parts of the respective sub-units.